Cabazitaxel for the Treatment of mCRPC: Data From the CARD Trial

Video

Dr Shore continues his review of data on cabazitaxel for the treatment of mCRPC by highlighting efficacy data from the CARD trial and real-world data that could impact practice.

Related Videos
Brian T. Helfand, MD, and Matthew Smith, MD, PhD, experts on prostate cancer
Brian T. Helfand, MD, and Matthew Smith, MD, PhD, experts on prostate cancer
blur image background of corridor in hospital or clinic image | Image Credit: © whyframeshot - stock.adobe.com
Jill M. Hamilton Reeves, PhD, RD, CSO, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.